Carlisle Companies News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

23.04.19	Carlisle Q1 Profit Tops Estimates; Shares Rise 5% - Quick Facts (RTTNews)
22.04.19	Ausblick: Carlisle Companies öffnet die Bücher zum abgelaufenen Quartal (finanzen.net)
06.02.19	Ausblick: Carlisle Companies stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
17.01.19	ECB hawk Lautenschlaeger has not given up on 2019 rate hike: Politico (Reuters)
22.10.18	Ausblick: Carlisle Companies öffnet die Bücher zum abgelaufenen Quartal (finanzen.net)
24.08.18	Fed policymakers see rate hikes, blurring dove-hawk divide (Reuters)
23.08.18	ECB hawk Weidmann sees chances dimming of succeeding Draghi (Reuters)
23.08.18	ECB hawk Weidmann sees chances dim of succeeding Draghi (Reuters)
24.07.18	Carlisle Companies Inc. Q2 Income Advances (RTTNews)
31.05.18	IDELVION® Newly Approved 3500 IU Vial to Provide Convenience to Patients Using Larger Volumes (PR Newswire)
14.05.18	Hemophilia Association Of New Jersey Recognizes CSL CEO Paul Perreault As "Humanitarian Man Of The Year" (PR Newswire)
06.05.18	Carlisle Companies Announces Director Change (RTTNews)
26.04.18	Patient Advocacy Groups Focus On Key Issues Affecting Patients (PR Newswire)
25.04.18	New College Ranking and Review Aggregator Publishes Top Consensus Ranked Regional Universities in Midwest for 2018 (PR Newswire)
24.04.18	Carlisle Companies Issues FY18 Revenue Guidance - Quick Facts (RTTNews)
24.04.18	Carlisle Companies Inc. Q1 Earnings Rise (RTTNews)
20.04.18	CSL Behring, Leader in Rare Diseases, Showcases Innovations in Neuromuscular Medicine (NMM) at the 2018 American Academy of Neurology Annual Meeting (PR Newswire)
19.04.18	The Lancet publishes results demonstrating adjuvanted quadrivalent influenza vaccine provides significantly greater efficacy in children 6 through 23 months (PR Newswire)
12.04.18	Life-Saving Medicines Donated For Patients In The Developing World (PR Newswire)
23.03.18	CSL Behring Announces First Patient Enrollment in Phase 3 Clinical Trial of CSL112 to Assess Reduction of Early Recurrent Cardiovascular Events in Heart Attack Survivors (PR Newswire)
23.03.18	CSL Behring Announces First Patient Enrollment in Phase 3 Clinical Trial of CSL112 to Assess Reduction of Early Recurrent Cardiovascular Events in Heart Attack Survivors (PR Newswire)
20.03.18	Forbes Magazine Names CSL Limited Among Top 50 Employers in the World (PR Newswire)
16.03.18	FDA Approves Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (PR Newswire)
15.03.18	CSL Behring Receives Patient Impact Award For Subcutaneous Prophylactic Treatment To Prevent Hereditary Angioedema Attacks (PR Newswire)
13.03.18	CSL CEO Paul Perreault Calls on Industry to Improve Patients' Access to Medicines (PR Newswire)
13.03.18	CSL CEO Paul Perreault Calls on Industry to Improve Patients' Access to Medicines (PR Newswire)
13.03.18	Seqirus answers the call for better and faster influenza vaccine technologies (PR Newswire)
07.03.18	CFSP Acquisition Corp. -- Moody's assigns B3 CFR to Carlisle FoodService; B2 to secured first lien facility (Moodys)
08.02.18	Carlisle Companies Inc. Bottom Line Advances In Q4 (RTTNews)
01.02.18	Carlisle Companies To Sell Carlisle FoodService Products For $750 Mln In Cash (RTTNews)
07.12.17	Rogers Communications announces changes to Board of Directors (PR Newswire)
05.12.17	CSL and Vitaeris Announce Strategic Partnership with Option to Acquire (PR Newswire)
05.12.17	CSL and Vitaeris Announce Strategic Partnership with Option to Acquire (PR Newswire)
05.12.17	CSL and Vitaeris Announce Strategic Partnership with Option to Acquire (PR Newswire)
04.12.17	CSL Behring Advances to Phase 3 Cardiovascular Outcomes Trial for CSL112, its Novel Apolipoprotein A-I (Human) Infusion Therapy (PR Newswire)
16.11.17	SQI Diagnostics Reports Fourth Quarter and Fiscal 2017 Results (PR Newswire)
13.11.17	Carlisle Companies Incorporated -- Moody's affirms Carlisle Companies' Baa2 senior unsecured rating; assigns Baa2 senior unsecured rating to proposed notes issuance (Moodys)
09.11.17	Lancet Neurology Publishes Results from CSL Behring Phase III Study of Hizentra® (Immune Globulin Subcutaneous [Human] 20% liquid) as Maintenance Therapy in Patients with Chronic Inflammatory... (PR Newswire)
29.10.17	Data on the Preventive Effects of HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) in Subjects with Very Frequent HAE Attacks Presented by CSL Behring at the 2017 ACAAI Annual Scientific Meeting (PR Newswire)
24.10.17	Carlisle Companies Inc. Q3 Earnings Decline 24% (RTTNews)
24.10.17	New Data for HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) to be presented at the 2017 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Carlisle Companies Inc.

Aktien Top/Flop

Meistgelesene Nachrichten